Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 64
Filter
1.
J Anim Sci Biotechnol ; 6(1): 31, 2015.
Article in English | MEDLINE | ID: mdl-26244091

ABSTRACT

BACKGROUND: Cortisol is secreted into blood in reaction to acute stress, but also in phases of diminished feed intake and changed animal behavior. As cows do not always show clear signs of discomfort, reliable diagnostic markers could be used to provide information regarding individual cows' distress. The objective of this study was to establish an ether free immunoassay for the detection of cortisol and to determine values during the first 22 weeks of lactation. Furthermore, the response in milk cortisol levels was assessed during times of metabolic stress and pain associated symptoms of lameness. METHODS: Milk yield and composition, blood serum glucose, NEFA and BHBA as well as milk cortisol were determined in 24 multiparous Holstein-Friesian cows over the course of the first 22 weeks of lactation. Animals were further checked for signs of clinical diseases on a daily basis. Two feed restrictions over three days (FR; 70 % of precious ad libitum intake) were performed during the 4(th) wk and the 21(st) wk, respectively. An ELISA for cortisol measurement in easily accessible bovine skimmed milk was established and applied. RESULTS: On the last day of FR in early lactation, a reduction in milk yield and changes in serum metabolites compared to respective previous values were detected. The FR in mid-lactation resulted in no changes in milk production and serum metabolites. Milk cortisol was highest during first wk of lactation and remained on comparable levels thereafter. Milk yield and composition were not influenced by FR. Lameness resulted in enhanced milk cortisol levels. CONCLUSION: Milk cortisol could be used as an indicator of painful symptoms such as lameness. Higher values of milk cortisol levels during first wk of lactation should be taken into account for interpretation.

2.
BMC Genomics ; 15: 941, 2014 Oct 27.
Article in English | MEDLINE | ID: mdl-25348288

ABSTRACT

BACKGROUND: Previously we have examined the effect of maternal dietary n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy on offspring fat mass. Considering the involvement of the placenta in fetal programming, we aimed to analyze the sex-specific gene expression in human term placenta and its response to the n-3 LCPUFA intervention, as well as their correlations to offspring adiposity. RESULTS: Placental gene expression was assessed in a control and n-3 LCPUFA intervention group by DNA microarrays, biological pathway analyses and RT-qPCR validation. Expression data were correlated with sex steroid hormone levels in placenta and cord plasma, and offspring anthropometric data. Transcriptome data revealed sexually dimorphic gene expression in control placentas per se, whereas in intervention placentas sex-specific expression changed, and more n-3 LCPUFA-regulated genes were found in female than male placentas. Sexually dimorphic gene expression and n-3 LCPUFA-responsive genes were enriched in the pathway for cell cycle and its associated modulator pathways. Significant mRNA expression changes for CDK6, PCNA, and TGFB1 were confirmed by RT-qPCR. CDK6 and PCNA mRNA levels correlated with offspring birth weight and birth weight percentiles. Significantly reduced placental estradiol-17ß/testosterone ratio upon intervention found in female offspring correlated with mRNA levels for the 'Wnt signaling' genes DVL1 and LRP6. CONCLUSIONS: Overall, human placentas show sexually dimorphic gene expression and responsiveness to maternal n-3 LCPUFA intervention during pregnancy with more pronounced effects in female placentas. The absence of correlations of analyzed placental gene expression with offspring adipose tissue growth in the first year is not mutually exclusive with programming effects, which may manifest later in life, or in other physiological processes.


Subject(s)
Fatty Acids, Omega-3/pharmacology , Fetal Blood/metabolism , Gene Expression Regulation/drug effects , Placenta/metabolism , Birth Weight , Cell Cycle , Female , Gene Expression Profiling , Gonadal Steroid Hormones/metabolism , Humans , Oligonucleotide Array Sequence Analysis , Pregnancy , Randomized Controlled Trials as Topic , Sex Characteristics , Wnt Signaling Pathway
3.
Anim Reprod Sci ; 146(3-4): 148-56, 2014 May.
Article in English | MEDLINE | ID: mdl-24703368

ABSTRACT

This study aimed to evaluate the effect of different phases of feed restriction on the metabolism and placental indices of growing heifers inseminated with sexed semen of one bull and on the birth weights of their calves. Red-Holstein heifers were randomly divided into three groups. C-group animals (N=17) daily received recommended energy and crude protein (standard diet). ER-Group animals (N=14) were fed 60% of recommended energy and crude protein for the first two pregnancy months followed by the standard diet. LR-group animals (N=13) were provided with the standard diet throughout the first seven months and with 60% energy and crude protein for the last two months of pregnancy. Blood metabolites and weights of dams were assessed regularly during pregnancy. Placenta weight, area of placentomes and calves' birth weights were examined directly after birth. The physiological levels of blood metabolites varied in C-group animals during the different pregnancy stages. Both restriction periods resulted in reduced weight gain of the dams. ER-group animals showed a marked compensatory growth during mid-pregnancy. Serum glucose, cholesterol and beta-hydroxybutyrate were lower in ER-group animals compared with C-group animals during early restriction. During late restriction, only non-esterified fatty acids increased in LR-group animals. Placental parameter and calves' birth weights did not differ between groups. Results indicate only minor effects of a 40% energy and protein restriction during early or late pregnancy in growing heifers on maternal metabolic and placental indices as well as on foetal development, but further studies might show long-term consequences of offspring.


Subject(s)
Birth Weight , Energy Metabolism/physiology , Food Deprivation , Nutritional Status , Placenta/anatomy & histology , Animal Feed , Animals , Cattle , Diet/veterinary , Energy Metabolism/genetics , Female , Male , Pregnancy , Sex Preselection/veterinary
4.
J Dairy Res ; 81(1): 120-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24351793

ABSTRACT

The main goal of this experiment was to study the effect of milk fat depression, induced by supplementing diet with plant oils, on the bovine fat metabolism, with special interest in cholesterol levels. For this purpose 39 cows were divided in three groups and fed different rations: a control group (C) without any oil supplementation and two groups with soybean oil (SO) or rapeseed oil (RO) added to the partial mixed ration (PMR). A decrease in milk fat percentage was observed in both oil feedings with a higher decrease of -1·14 % with SO than RO with -0·98 % compared with the physiological (-0·15 %) decline in the C group. There was no significant change in protein and lactose yield. The daily milk cholesterol yield was lower in both oil rations than in control ration, while the blood cholesterol level showed an opposite variation. The milk fatty acid pattern showed a highly significant decrease of over 10 % in the amount of saturated fatty acids (SFA) in both oil feedings and a highly significant increase in mono (MUFA) and poly (PUFA) unsaturated fatty acids, conjugated linoleic acids (CLA) included. The results of this experiment suggest that the feeding of oil supplements has a high impact on milk fat composition and its significance for human health, by decreasing fats with a potentially negative effect (SFA and cholesterol) while simultaneously increasing others with positive (MUFA, PUFA, CLA).


Subject(s)
Cattle/metabolism , Cholesterol/analysis , Lipid Metabolism , Milk/chemistry , Plant Oils/administration & dosage , Soybean Oil/administration & dosage , Animals , Cholesterol/blood , Diet/veterinary , Dietary Supplements , Fats/analysis , Fatty Acids/analysis , Fatty Acids, Monounsaturated , Female , Lactation , Lactose/analysis , Milk Proteins/analysis , Rapeseed Oil
5.
J Steroid Biochem Mol Biol ; 138: 435-44, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24056088

ABSTRACT

Early exposure to environmental estrogens may exert lasting impacts on health. In rodents, homeobox A10 (HOXA10) was demonstrated to be a target of early endocrine disruption, as indicated by persistent changes in uterine HOXA10 expression and promoter DNA methylation in the offspring. This study aimed at analyzing long-term effects of estradiol-17ß on porcine uterine HOXA10. Therefore, offspring were exposed in utero to low (0.05 and 10µg/kg body weight/day) and high (1000µg/kg body weight/day) doses, respectively. We, furthermore, investigated whether promoter DNA methylation was generally involved in regulating HOXA10 expression. Unexpectedly, the maternal estrogen exposure did not distinctly impact HOXA10 expression and promoter DNA methylation in either pre- or postpubertal offspring. Although differential HOXA10 expression was observed in endometrial tissue during the estrous cycle and the pre-implantation period, no concurrent substantial changes occurred regarding promoter DNA methylation. However, by comparing several tissues displaying larger differences in transcriptional abundance, HOXA10 expression correlated with promoter DNA methylation in prepubertal, but not postpubertal, gilts. Thus, promoter DNA methylation could affect gene expression in pigs, depending on their stage of development. Clearly, early estrogen exposure exerted other effects in pigs as known from studies in rodents. This may be due to endocrine differences as well as to species-specific peculiarities of tissue sensitivity to estradiol-17ß during critical windows of development.


Subject(s)
DNA Methylation/drug effects , Estradiol/pharmacology , Homeodomain Proteins/genetics , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism , Animals , Female , Swine
6.
PLoS One ; 7(11): e50350, 2012.
Article in English | MEDLINE | ID: mdl-23209719

ABSTRACT

The primary gestagen of elephants is 5α-dihydroprogesterone (DHP), which is unlike all other mammals studied until now. The level of DHP in elephants equals that of progesterone in other mammals, and elephants are able to bind DHP with similar affinity to progesterone indicating a unique ligand-binding specificity of the elephant progestin receptor (PR). Using site-directed mutagenesis in combination with in vitro binding studies we here report that this change in specificity is due to a single glycine to alanine exchange at position 722 (G722A) of PR, which specifically increases DHP affinity while not affecting binding of progesterone. By conducting molecular dynamics simulations comparing human and elephant PR ligand-binding domains (LBD), we observed that the alanine methyl group at position 722 is able to push the DHP A-ring into a position similar to progesterone. In the human PR, the DHP A-ring position is twisted towards helix 3 of PR thereby disturbing the hydrogen bond pattern around the C3-keto group, resulting in a lower binding affinity. Furthermore, we observed that the elephant PR ligand-binding pocket is more rigid than the human analogue, which probably explains the higher affinity towards both progesterone and DHP. Interestingly, the G722A substitution is not elephant-specific, rather it is also present in five independent lineages of mammalian evolution, suggesting a special role of the substitution for the development of distinct mammalian gestagen systems.


Subject(s)
Receptors, Progesterone/chemistry , Receptors, Progesterone/metabolism , 5-alpha-Dihydroprogesterone/metabolism , Alanine/genetics , Animals , Cloning, Molecular , Elephants , Glycine/genetics , Horses , Humans , Hydrogen Bonding , Hyraxes , Ligands , Models, Chemical , Models, Molecular , Molecular Dynamics Simulation , Mutagenesis, Site-Directed , Phylogeny , Protein Binding , Protein Structure, Tertiary , Trichechus
7.
Anal Chem ; 84(15): 6863-8, 2012 Aug 07.
Article in English | MEDLINE | ID: mdl-22861009

ABSTRACT

The abuse of anabolic substances in animal husbandry is forbidden within the EU and well controlled by detecting substance residues in different matrices. The application of newly designed drugs or substance cocktails represents big problems. Therefore developing sensitive test methods is important. The analysis of physiological changes caused by the use of anabolic agents on the molecular level, for example, by quantifying gene expression response, is a new approach to develop such screening methods. A novel technology for holistic gene expression analysis is RNA sequencing. In this study, the potential of this high-throughput method for the identification of biomarkers was evaluated. The effect of trenbolone acetate plus estradiol on gene expression in liver from Nguni heifers was analyzed with RNA sequencing. The expression of 40 selected candidate genes was verified via RT-qPCR, whereby 20 of these genes were significantly regulated. To extract the intended information from these regulated genes, biostatistical tools for pattern recognition were applied and resulted in a clear separation of the treatment groups. Those candidate genes could be verified in boars and in calves treated with anabolic substances. These results show the potential of RNA sequencing to screen for biomarker candidates to detect the abuse of anabolics. The verification of these biomarkers in boars and calves leads to the assumption that gene expression biomarkers are independent of breed or even species and that biomarkers, identified in farm animals could also act as potential biomarker candidates to detect the abuse of anabolic substances in human sports.


Subject(s)
Anabolic Agents/pharmacology , Sequence Analysis, RNA , Animals , Biomarkers/metabolism , Cluster Analysis , Doping in Sports , Estradiol/pharmacology , Horses , Liver/drug effects , Liver/metabolism , Principal Component Analysis , Transcriptome , Trenbolone Acetate/pharmacology
8.
Drug Test Anal ; 4 Suppl 1: 70-4, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22851363

ABSTRACT

The use of growth-promoting agents in food-producing animals is forbidden in the European Union (EU). Therefore a strict control programme has been developed, detecting residues of all known growth-promoting agents using chromatographical methods in combination with mass spectrometry or immunoassays. New designed xenobiotic substances or hormone cocktails are difficult to identify with these methods and therefore the development of new sensitive test methods is important. A promising indirect approach is the detection of physiological effects of the administered growth promoters on the molecular level using 'omic' technologies. The analysis of the transcriptome on mRNA and miRNA level and thereby identifying biomarkers for the use of anabolic agents is one possible strategy for developing a new screening method. This paper describes the technologies available for gene expression profiling and summarizes the efforts made in the analysis of the transcriptome in order to identify potential gene expression biomarkers for the use of growth promoters in cattle.


Subject(s)
Anabolic Agents/analysis , Gene Expression Profiling/methods , Gene Expression Profiling/veterinary , Hormones/analysis , RNA/genetics , Anabolic Agents/metabolism , Animals , Cattle , Hormones/metabolism , Substance Abuse Detection/methods , Substance Abuse Detection/veterinary , Transcriptome
9.
Toxicol Appl Pharmacol ; 263(3): 338-44, 2012 Sep 15.
Article in English | MEDLINE | ID: mdl-22819784

ABSTRACT

Endocrine disrupting chemicals with estrogenic activity play an important role as obesogens. However, studies investigating the most potent natural estrogen, estradiol-17ß (E2), at low dose are lacking. We examined endocrine and physiological parameters in gilts receiving distinct concentrations of E2 during pregnancy. We then investigated whether adverse effects prevail in progeny due to a potential endocrine disruption. E2 was orally applied to gilts during the entire period of pregnancy. The concentrations represented a daily consumption at the recommended ADI level (0.05 µg/kg body weight/day), at the NOEL (10 µg/kg body weight/day) and at a high dosage (1000 µg/kg body weight/day). Plasma hormone concentrations were determined using enzyme immuno assays. Offspring body fat was assessed by dual-energy X-ray absorptiometry scanning. In treated gilts receiving 1000µg E2/kg body weight/day we found significantly elevated plasma E2 levels during pregnancy, paralleled by an increased weight gain. While offspring showed similar weight at birth, piglets exhibited a significant reduction in weight at weaning even though their mothers had only received 0.05 µg E2/kg body weight/day. At 8 weeks of age, specifically males showed a significant increase in overall body fat percentage. In conclusion, prenatal exposure to low doses of E2 affected pig offspring development in terms of body weight and composition. In line with findings from other obesogens, our data suggest a programming effect during pregnancy for E2 causative for the depicted phenotypes. Therefore, E2 exposure may imply a possible contribution to childhood obesity.


Subject(s)
Body Composition/drug effects , Estradiol/toxicity , Estrogens/toxicity , Prenatal Exposure Delayed Effects , Absorptiometry, Photon , Adipose Tissue/drug effects , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Endocrine Disruptors/administration & dosage , Endocrine Disruptors/blood , Endocrine Disruptors/toxicity , Estradiol/administration & dosage , Estradiol/blood , Estrogens/administration & dosage , Estrogens/blood , Female , Immunoenzyme Techniques , Male , No-Observed-Adverse-Effect Level , Obesity/etiology , Pregnancy , Sex Factors , Swine
10.
J Steroid Biochem Mol Biol ; 130(1-2): 96-104, 2012 May.
Article in English | MEDLINE | ID: mdl-22342840

ABSTRACT

DNA methylation of the promoter region of estrogen receptor alpha (ESR1) is recognized as an epigenetic mechanism that regulates its mRNA abundance. We questioned whether tissues in male growing piglets were influenced in terms of DNA methylation by the developmentally occurring distinct plasma estradiol-17ß (E2) concentrations. Additionally, we aimed at broadening the currently limited understanding of the epigenetic regulation of ESR1 in physiological settings. Three distinct genetic regions of ESR1 were analyzed using a combination of methylation-sensitive high resolution melting (MS-HRM) and pyrosequencing. Unexpectedly, major E2 concentration differences were only marginally associated with minor variations in DNA methylation and mRNA abundance. However, by analyzing two tissues showing the greatest differences in transcript abundance, we were able to find one single CpG site in the +1kb intragenic region of ESR1 strikingly differently methylated between heart vs. epididymis. Interestingly, this single CpG-site was identified as a putative binding site for the transcriptional repressor TG-interacting factor 1 (TGIF) which can recruit histone deacetylase 1 (HDAC1) leading to chromatin condensation. Indeed, chromatin immunoprecipitation confirmed a reduced histone H3 presence at the specific ESR1 location in case of higher DNA methylation. We therefore hypothesize that ESR1 expression may be manifested by a single-CpG-site based methylation difference impairing transcription factor binding.


Subject(s)
CpG Islands , Estrogen Receptor alpha/genetics , Transcription, Genetic , Animals , Chromatin Immunoprecipitation , DNA Methylation , Estrogen Receptor alpha/metabolism , Histone Deacetylase 1/metabolism , Male , RNA, Messenger/metabolism , Swine
11.
Transgenic Res ; 21(1): 77-88, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21499757

ABSTRACT

Cultivation of genetically modified maize (Bt-maize; event MON810) producing recombinant δ-endotoxin Cry1Ab, leads to introduction of the insecticidal toxin into soil by way of root exudates and plant residues. This study investigated the fate of Cry1Ab in soil under long-term Bt-maize cultivation in an experimental field trial performed over nine growing seasons on four South German field sites cultivated with MON810 and its near isogenic non Bt-maize variety. Cry1Ab protein was quantified in soil (<2 mm size) using an in-house validated ELISA method. The assay was validated according to the criteria specified in European Commission Decision 2002/657/EC. The assay enabled quantification of Cry1Ab protein at a decision limit (CCα) of 2.0 ng Cry1Ab protein g(-1) soil with analytical recovery in the range 49.1-88.9%, which was strongly correlated with clay content. Cry1Ab protein was only detected on one field site at concentrations higher than the CCα, with 2.91 and 2.57 ng Cry1Ab protein g(-1) soil in top and lower soil samples collected 6 weeks after the eighth growing season. Cry1Ab protein was never detected in soil sampled in the spring before the next farming season at any of the four experimental sites. No experimental evidence for accumulation or persistence of Cry1Ab protein in different soils under long-term Bt-maize cultivation can be drawn from this field study.


Subject(s)
Bacterial Proteins/analysis , Endotoxins/analysis , Hemolysin Proteins/analysis , Plants, Genetically Modified , Soil/analysis , Zea mays/genetics , Agriculture/methods , Bacillus thuringiensis Toxins , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Endotoxins/genetics , Endotoxins/metabolism , Enzyme-Linked Immunosorbent Assay , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Longitudinal Studies
12.
Mol Cell Endocrinol ; 348(1): 67-77, 2012 Jan 02.
Article in English | MEDLINE | ID: mdl-21802491

ABSTRACT

Epigenetic events controlling the transcriptional regulation of genes involved in endometrial function during the estrous cycle and early pregnancy have only sparsely been investigated. We analyzed the gene expression of DNA methyltransferases and the most prominent endocrine transcriptional mediator estrogen receptor alpha (ESR1) in the bovine endometrium of heifers at 0, 12 and 18 days following estrous and at day 18 after insemination. The luminometric methylation assay for the investigation of global DNA methylation and an elegant combination of methylation-sensitive high resolution melting and pyrosequencing for local methylation levels of ESR1 were deployed. In spite of differential gene expression of ESR1 among groups, no differences in endometrial ESR1 DNA methylation during neither estrous cycle nor early pregnancy were determined. Global DNA methylation prevailed at similar low levels in endometrium, likely controlled by the observed moderate DNMT3b expression. Thus, the epigenetic contribution of DNA methylation influencing endometrial function seems rather limited. However, because a control tissue expressing only minute amounts of ESR1 transcripts was locally significantly higher methylated, DNA methylation might contribute to an appropriate tissue-specific expression status underlying further specific control mechanisms of gene transcription.


Subject(s)
DNA Methylation , Endometrium/metabolism , Epigenesis, Genetic , Estrous Cycle , Pregnancy, Animal/genetics , Transcription, Genetic , Animals , Cattle , DNA Modification Methylases/genetics , DNA Modification Methylases/metabolism , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Female , Gene Expression , Polymerase Chain Reaction , Pregnancy , Pregnancy, Animal/metabolism , RNA, Messenger/metabolism , Regression Analysis , Sequence Analysis, DNA/methods , Transition Temperature
13.
Biol Reprod ; 86(2): 46, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22034527

ABSTRACT

Interferon tau (IFNT), a type I IFN similar to alpha IFNs (IFNA), is the pregnancy recognition signal produced by the ruminant conceptus. To elucidate specific effects of bovine IFNT and of other conceptus-derived factors, endometrial gene expression changes during early pregnancy were compared to gene expression changes after intrauterine application of human IFNA2. In experiment 1, endometrial tissue samples were obtained on Day (D) 12, D15, and D18 postmating from nonpregnant or pregnant heifers. In experiment 2, heifers were treated from D14 to D16 of the estrous cycle with an intrauterine device releasing IFNA2 or, as controls, placebo lipid extrudates or PBS only. Endometrial biopsies were performed after flushing the uterus. All samples from both experiments were analyzed with an Affymetrix Bovine Genome Array. Experiment 1 revealed differential gene expression between pregnant and nonpregnant endometria on D15 and D18. In experiment 2, IFNA2 treatment resulted in differential gene expression in the bovine endometrium. Comparison of the data sets from both studies identified genes that were differentially expressed in response to IFNA2 but not in response to pregnancy on D15 or D18. In addition, genes were found that were differentially expressed during pregnancy but not after IFNA2 treatment. In experiment 3, spatiotemporal alterations in expression of selected genes were determined in uteri from nonpregnant and early pregnant heifers using in situ hybridization. The overall findings of this study suggest differential effects of bovine IFNT compared to human IFNA2 and that some pregnancy-specific changes in the endometrium are elicited by conceptus-derived factors other than IFNT.


Subject(s)
Endometrium/metabolism , Gene Expression/drug effects , Interferon-alpha/pharmacology , Pregnancy, Animal/metabolism , Animals , Biopsy , Cattle , Endometrium/drug effects , Endometrium/pathology , Female , Humans , Interferon Type I/metabolism , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Models, Animal , Pregnancy , Pregnancy Proteins/metabolism , Progesterone/blood , Time Factors
14.
Drug Test Anal ; 3(10): 676-81, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21898858

ABSTRACT

The abuse of anabolic steroid hormones in human sports and animal husbandry is an ubiquitous problem and therefore a tight control program in both areas is very important. Within these control programs, hormone residues are detected by immunoassays or chromatographical methods in combination with mass spectrometry. With these methods, all known substances can be detected; yet new xenobiotic growth promoters and new ways of application are difficult to detect. Therefore it is important to develop new sensitive screening methods to enable an efficient control for misused anabolic substances. The detection of their physiological action is a promising approach. Anabolic steroid hormones directly influence the expression of specific genes and thus the analysis of the transcriptome of different target tissues and matrices is of great interest. This review describes our recent efforts made concerning the analysis of gene expression changes in different tissues, different species and under different anabolic treatments.


Subject(s)
Anabolic Agents/pharmacology , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Steroids/pharmacology , Substance Abuse Detection/methods , Animals , Humans , Transcriptome
15.
Cell Reprogram ; 13(5): 403-10, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21774685

ABSTRACT

Fetal overgrowth and placental abnormalities frequently occur in pregnancies following somatic cell nuclear transfer (SCNT). An optimal intrauterine supply of amino acids (AA) is of specific importance for the development of the bovine preimplantation embryo, and a defective regulation of AA supply might contribute to pregnancy failures. Thus, we analyzed 41 AA and derivatives by liquid chromatography-tandem mass spectrometry in uterine flushings of day 18 pregnant heifers carrying in vitro fertilized (IVF) or SCNT embryos, which were cultured under identical conditions until transfer to recipients. The concentrations of several AA were reduced in samples from SCNT pregnancies: L-leucine (1.8-fold), L-valine (1.6-fold), L-isoleucine (1.9-fold), L-phenylalanine (1.5-fold), L-glutamic acid (3.9-fold), L-aspartic acid (4.0-fold), L-proline (2.6-fold), L-alanine (2.0-fold), L-arginine (2.5-fold), and L-lysine (1.9-fold). The endometrial transcript abundance for the AA transporter solute carrier family 7 (amino acid transporter, L-type), member 8 (SLC7A8) was also 2.4-fold lower in SCNT pregnancies. O-phosphoethanolamine (PetN) was 11-fold (p=0.0001) reduced in the uterine fluid of animals carrying an SCNT conceptus, pointing toward changes of the phospholipid metabolism. We provide evidence for disturbed embryo-maternal interactions in the preimplantation period after transfer of SCNT embryos, which may contribute to developmental abnormalities. These are unlikely related to the major embryonic pregnancy recognition signal interferon-tau, because similar activities were detected in uterine flushings of the SCNT and IVF groups.


Subject(s)
Amino Acids/metabolism , Blastocyst/metabolism , Cloning, Organism , Endometrium/metabolism , Fertilization in Vitro , Gene Expression Regulation/physiology , Nuclear Transfer Techniques , Pregnancy/metabolism , Amino Acid Transport Systems/biosynthesis , Animals , Cattle , Embryonic Development/physiology , Female
16.
Genet Sel Evol ; 43: 24, 2011 Jun 24.
Article in English | MEDLINE | ID: mdl-21702919

ABSTRACT

BACKGROUND: During the past ten years many quantitative trait loci (QTL) affecting mastitis incidence and mastitis related traits like somatic cell score (SCS) were identified in cattle. However, little is known about the molecular architecture of QTL affecting mastitis susceptibility and the underlying physiological mechanisms and genes causing mastitis susceptibility. Here, a genome-wide expression analysis was conducted to analyze molecular mechanisms of mastitis susceptibility that are affected by a specific QTL for SCS on Bos taurus autosome 18 (BTA18). Thereby, some first insights were sought into the genetically determined mechanisms of mammary gland epithelial cells influencing the course of infection. METHODS: Primary bovine mammary gland epithelial cells (pbMEC) were sampled from the udder parenchyma of cows selected for high and low mastitis susceptibility by applying a marker-assisted selection strategy considering QTL and molecular marker information of a confirmed QTL for SCS in the telomeric region of BTA18. The cells were cultured and subsequently inoculated with heat-inactivated mastitis pathogens Escherichia coli and Staphylococcus aureus, respectively. After 1, 6 and 24 h, the cells were harvested and analyzed using the microarray expression chip technology to identify differences in mRNA expression profiles attributed to genetic predisposition, inoculation and cell culture. RESULTS: Comparative analysis of co-expression profiles clearly showed a faster and stronger response after pathogen challenge in pbMEC from less susceptible animals that inherited the favorable QTL allele 'Q' than in pbMEC from more susceptible animals that inherited the unfavorable QTL allele 'q'. Furthermore, the results highlighted RELB as a functional and positional candidate gene and related non-canonical Nf-kappaB signaling as a functional mechanism affected by the QTL. However, in both groups, inoculation resulted in up-regulation of genes associated with the Ingenuity pathways 'dendritic cell maturation' and 'acute phase response signaling', whereas cell culture affected biological processes involved in 'cellular development'. CONCLUSIONS: The results indicate that the complex expression profiling of pathogen challenged pbMEC sampled from cows inheriting alternative QTL alleles is suitable to study genetically determined molecular mechanisms of mastitis susceptibility in mammary epithelial cells in vitro and to highlight the most likely functional pathways and candidate genes underlying the QTL effect.


Subject(s)
Cattle/genetics , Escherichia coli Infections/veterinary , Genetic Predisposition to Disease , Mammary Glands, Animal/microbiology , Mastitis, Bovine/genetics , Staphylococcal Infections/veterinary , Animals , Cattle/metabolism , Cattle/microbiology , Cells, Cultured , Epithelial Cells/cytology , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Escherichia coli/physiology , Escherichia coli Infections/genetics , Escherichia coli Infections/metabolism , Escherichia coli Infections/microbiology , Female , Gene Expression Profiling , Male , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Mastitis, Bovine/metabolism , Mastitis, Bovine/microbiology , Quantitative Trait Loci , Staphylococcal Infections/genetics , Staphylococcal Infections/metabolism , Staphylococcal Infections/microbiology , Staphylococcus aureus/physiology
17.
J Agric Food Chem ; 59(13): 7135-44, 2011 Jul 13.
Article in English | MEDLINE | ID: mdl-21604675

ABSTRACT

The objective of the study was to track the fate of recombinant Cry1Ab protein in a liquid manure field trial when feeding GM maize MON810 to dairy cows. A validated ELISA was applied for quantification of Cry1Ab in the agricultural chain from GM maize plants, feed, liquid manure and soil to crops grown on manured fields. Starting with 23.7 µg of Cry1Ab g(-1) dry weight GM maize material, a rapid decline of Cry1Ab levels was observed as 2.6% and 0.9% of Cry1Ab from the GM plant were detected in feed and liquid manure, respectively. Half of this residual Cry1Ab persisted during slurry storage for 25 weeks. After application to experimental fields, final degradation of Cry1Ab to below detectable levels in soil was reported. Cry1Ab exhibited a higher rate of degradation compared to total protein in the agricultural processes. Immunoblotting revealed a degradation of the 65 kDa Cry1Ab into immunoreactive fragments of lower size in all analyzed materials.


Subject(s)
Animal Feed/analysis , Bacterial Proteins/analysis , Endotoxins/analysis , Hemolysin Proteins/analysis , Manure/analysis , Plants, Genetically Modified/genetics , Recombinant Proteins/analysis , Zea mays/genetics , Agriculture/methods , Bacillus thuringiensis Toxins , Bacterial Proteins/metabolism , Bacterial Proteins/pharmacokinetics , Endotoxins/metabolism , Endotoxins/pharmacokinetics , Hemolysin Proteins/metabolism , Hemolysin Proteins/pharmacokinetics , Soil/analysis , Zea mays/growth & development
18.
Reproduction ; 142(1): 41-52, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21543511

ABSTRACT

The present study investigated the role of IGF1 in lactating lean and non-lactating obese dairy cows by injecting 1 µg IGF1 into the ovaries prior to superovulation. This amount of IGF1 has been linked with pregnancy loss in women with the polycystic ovary syndrome (PCOS) and was associated with impaired bovine oocyte competence in vitro. Transcript abundance and protein expression of selected genes involved in apoptosis, glucose metabolism, and the IGF system were analyzed. Plasma concentrations of IGF1 and leptin, and IGF1 in uterine luminal fluid (ULF), were also measured. IGF1 treatment decreased embryo viability in lean cows to the levels observed in obese cows. Obese cows were not affected by IGF1 treatment and showed elevated levels of IGF1 (in both plasma and ULF) and leptin. Blastocysts from lean cows treated with IGF1 showed a higher abundance of SLC2A1 and IGFBP3 transcripts. IGF1 treatment reduced protein expression of tumor protein 53 in blastocysts of lean cows, whereas the opposite was observed in obese cows. IGF1 in plasma and ULF was correlated only in the control groups. Blastocyst transcript abundance of IGF1 receptor and IGFBP3 correlated positively with IGF1 concentrations in both plasma and ULF in lean cows. The detrimental microenvironment created by IGF1 injection in lean cows and the lack of effect in obese cows resemble to a certain extent the situation observed in PCOS patients, where IGF1 bioavailability is increased in normal-weight women but reduced in obese women, suggesting that this bovine model could be useful for studying IGF1 involvement in PCOS.


Subject(s)
Disease Models, Animal , Insulin-Like Growth Factor I/metabolism , Obesity/complications , Oogenesis , Polycystic Ovary Syndrome/physiopathology , Superovulation , Thinness/complications , Animals , Blastocyst/cytology , Blastocyst/metabolism , Cattle , Embryo Loss/etiology , Female , Gene Expression Regulation, Developmental , Glucose Transporter Type 1/genetics , Glucose Transporter Type 1/metabolism , Insulin-Like Growth Factor Binding Protein 3/genetics , Insulin-Like Growth Factor Binding Protein 3/metabolism , Insulin-Like Growth Factor I/administration & dosage , Insulin-Like Growth Factor I/analysis , Lactation/drug effects , Leptin/blood , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/metabolism , Pregnancy , RNA, Messenger/metabolism , Receptor, IGF Type 1/genetics , Receptor, IGF Type 1/metabolism , Tumor Suppressor Protein p53/metabolism , Uterus/metabolism
19.
Reproduction ; 141(5): 685-95, 2011 May.
Article in English | MEDLINE | ID: mdl-21383026

ABSTRACT

Amino acids (AAs) are crucial for the developing conceptus prior to implantation. To provide insights into the requirements of the bovine embryo, we determined the AA composition of the uterine fluid. At days 12, 15, and 18 post-estrus, the uteri of synchronized pregnant and non-pregnant Simmental heifers were flushed for the analysis of 41 AAs and their derivatives by liquid chromatography-tandem mass spectrometry. The ipsilateral endometrium was sampled for quantitative PCR. In addition to a pregnancy-dependent increase of the essential AAs (P<0.01), we detected elevated concentrations for most non-essential proteinogenic AAs. Histidine (His) and the expression of the His/peptide transporter solute carrier 15A3 (SLC15A3) were significantly increased at day 18 of pregnancy in vivo. In addition, SLC15A3 was predominantly stimulated by trophoblast-derived interferon-τ in stroma cells of an in vitro co-culture model of endometrial cells. Our results show an increased concentration of AAs most likely to optimally provide the elongating pre-attachment conceptus with nutrients.


Subject(s)
Amino Acids, Essential/metabolism , Blastocyst/metabolism , Embryo Implantation , Uterus/metabolism , Amino Acid Transport Systems/genetics , Amino Acid Transport Systems/metabolism , Analysis of Variance , Animals , Biological Transport , Cattle , Cell Communication , Cells, Cultured , Chromatography, Liquid , Coculture Techniques , Estrus , Female , Gene Expression Regulation , Interferon Type I/metabolism , Linear Models , Pregnancy , Pregnancy Proteins/metabolism , Stromal Cells/metabolism , Tandem Mass Spectrometry , Time Factors , Trophoblasts/metabolism , Up-Regulation , Uterus/cytology
20.
J Agric Food Chem ; 59(4): 1423-7, 2011 Feb 23.
Article in English | MEDLINE | ID: mdl-21268636

ABSTRACT

The aim of this study was to collect further data about levels of endogenous hormones in foodstuffs derived from animal production. Because of expected higher concentrations of especially estrogens in colostrum compared to other foodstuffs, our investigation focused on this matrix. For evaluation of endogenous steroid hormones in separated colostrum (fat and defatted fraction) and colostrum powder, the relevant free and conjugated estrogens (estradiol-17ß, estradiol-17α, estrone, and estriol) androgens (androstendione, 19nor-androstendione, 19nor-testosterone-17ß, 19nor-testosterone-17α, testosterone-17ß, and testosterone-17α), and progesterone were determined by means of liquid chromatography-tandem mass spectrometry (LC-MS/MS). Upmost determined concentrations were found in the fat fraction, with 25.56 and 7.59 µg/L for estrone and androstendione, respectively. In defatted milk and colostrum powder, conjugated estrogens dominated, whereas total (free and conjugated) estrone (5.51 µg/L; 15.0 µg/kg) exceeded estradiol-17α (2.66 µg/L; 7.5 µg/kg) and estradiol-17ß (2.28 µg/L; 3.3 µg/kg). Neither 19nor-steroids nor estriol were detected in colostrum fractions or processed colostrum.


Subject(s)
Cattle/metabolism , Chromatography, Liquid , Colostrum/chemistry , Hormones/analysis , Tandem Mass Spectrometry , Androgens/analysis , Animals , Estrogens, Conjugated (USP)/analysis , Fats/analysis , Female , Milk/chemistry , Progesterone/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...